HOME > TOP STORIES
TOP STORIES
-
BUSINESS Takeda Vaults to 9th in Global Pharma Ranking after Shire Buy, Roche Tops List: Jiho Tally
February 21, 2020
-
BUSINESS GSK Japan Resurrects “Sales” for Rep Performance Review, Doctor Payments; Critics Say It’s a Rollback
February 20, 2020
-
BUSINESS Japan Pharma Market Logs 1st Growth in 3 Years in 2019, Keytruda Is the Best-Seller: IQVIA
February 19, 2020
-
REGULATORY Authorized Generics for Memary, Celecox among Approval List towards June Listing
February 18, 2020
-
REGULATORY MHLW Panel to Review Nippon Shinyaku’s Oligonucleotide DMD Drug, Latuda and More on Feb. 28
February 18, 2020
-
REGULATORY Zolgensma Up for Japan Advisory Panel Meeting on Feb. 26, Listing Expected as Early as May
February 17, 2020
-
BUSINESS Eisai Pulls Belviq from US Market after FDA Flags Cancer Risks
February 17, 2020
-
REGULATORY MHLW to Weigh All-Year Invitation for Sakigake Requests: Top Pharmacy Officer
February 14, 2020
-
BUSINESS Ono Revamps Japan Sales Structure to Gear Up for New Launches
February 13, 2020
-
REGULATORY MHLW Calls for Stable Supplies of HIV Drugs amid Coronavirus Outbreak
February 13, 2020
-
BUSINESS With 2 New Deals Inked, Meiji Hunkering Down for Full-Scale Entry into Hematology Market
February 12, 2020
-
ORGANIZATION FPMAJ Creates Scheme to Deal with Drug Supply Disruptions; Companies to Set Up “Supply Adjustment Teams”
February 12, 2020
-
INTERVIEW Improper Materials Apparently Decreased after Promotion Guidelines Introduced: Pharmacist
February 10, 2020
-
BUSINESS With Orix Deal, Reborn Kobayashi Kako Aims to Become Follow-Up to Big 3 Generic Players
February 7, 2020
-
ORGANIZATION RAD-AR Council Accelerating Initiative to Prepare Medication Guides in English toward Tokyo 2020 Olympic and Paralympic Games
February 6, 2020
-
ORGANIZATION Japan Red Cross Set to Push Formularies at All Group Hospitals, Despite Medical Fee Plan Dropped
February 5, 2020
-
BUSINESS Oncolys Hopes for Chugai’s Participation in US Development of Telomelysin: Chief
February 4, 2020
-
BUSINESS Opdivo Sales Drop 4.7% in April-December, but Ono Secures Higher Profits
February 3, 2020
-
BUSINESS Chugai Ups Core EPS CAGR Target to “Around 30%”: 3-Year Biz Plan
January 31, 2020
-
BUSINESS Chugai’s 2019 Earnings Renews Record for Third Year on Hemlibra, Tecentriq
January 31, 2020
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
